Adaptive Biotechnologies Corp
ADPT· Nasdaq
Released Aug 5, 2025, after the close
10-Q filed Aug 5, 2025, 36 days after period end · 0000950170-25-103120
| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Revenue | $58.88M | $43.19M | $48.93M | $43.66M |
| Net Income | -$25.61M | -$46.22M | -$47.81M | -$52.05M |
| EPS Diluted |
Adaptive Biotechnologies Corp · CIK 1478320 · Engraved from SEC EDGAR
| -$0.17 |
| -$0.31 |
| -$0.33 |
| -$0.37 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.